Aleksandr Kamyshnyi (Oleksandr Kamyshnyi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 54

Top Topics

Systematic Review

Respiratory Syndrome Coronavirus

Signaling Pathway

Gene Expression

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense. Microorganisms 12 (3) (2024)
Pavlo Petakh, Mykhailo Poliak, Anton Kohutych, Valentyn Oksenych, Aleksandr Kamyshnyi
Impact of Antibiotic and Steroid Therapy on Leptospirosis Outcomes: A Retrospective Cohort Study in Transcarpathia, Ukraine. Biomedicines 12 (8) (2024)
Belenichev Igor F, Victor Ryzhenko, Olena Popazova, Nina Bukhtiyarova, Nadia Gorchakova, Valentyn Oksenych, Aleksandr Kamyshnyi
Optimization of the Search for Neuroprotectors among Bioflavonoids. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Belenichev Igor F, Olena Aliyeva, Bogdan Burlaka, Kristina Burlaka, Kuchkovskyi Oleh M, Dmytro Savchenko, Valentyn Oksenych, Aleksandr Kamyshnyi
Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Iryna Halabitska, Liliia Babinets, Valentyn Oksenych, Aleksandr Kamyshnyi
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions. Biomedicines 12 (8) (2024)
Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense. Microorganisms 12 (3) (2024)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Aleksandr Kamyshnyi
Metformin Alters mRNA Expression of FOXP3 , RORC , and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses 16 (2) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Igor Belenichev, Olena Popazova, Nina Bukhtiyarova, Dmytro Savchenko, Valentyn Oksenych, Aleksandr Kamyshnyi
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection. Antioxidants (Basel, Switzerland) 13 (5) (2024)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Aleksandr Kamyshnyi
Metformin Alters mRNA Expression of FOXP3 , RORC , and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses 16 (2) (2024)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Aleksandr Kamyshnyi
Metformin Alters mRNA Expression of FOXP3 , RORC , and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses 16 (2) (2024)
Andrii Kamenshchyk, Belenichev Igor F, Valentyn Oksenych, Aleksandr Kamyshnyi
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes. Biomolecules 14 (4) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Belenichev Igor F, Olena Aliyeva, Bogdan Burlaka, Kristina Burlaka, Kuchkovskyi Oleh M, Dmytro Savchenko, Valentyn Oksenych, Aleksandr Kamyshnyi
Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia. Pharmaceuticals (Basel, Switzerland) 17 (8) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska, Aleksandr Kamyshnyi
Modulatory Roles of AHR , FFAR2 , FXR , and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes. Viruses 16 (6) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Pavlo Petakh, Valentyn Oksenych, Yevheniya Khovpey, Aleksandr Kamyshnyi
Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Belenichev Igor F, Victor Ryzhenko, Olena Popazova, Nina Bukhtiyarova, Nadia Gorchakova, Valentyn Oksenych, Aleksandr Kamyshnyi
Optimization of the Search for Neuroprotectors among Bioflavonoids. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Igor Belenichev, Olena Popazova, Nina Bukhtiyarova, Dmytro Savchenko, Valentyn Oksenych, Aleksandr Kamyshnyi
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection. Antioxidants (Basel, Switzerland) 13 (5) (2024)
Andrii Kamenshchyk, Belenichev Igor F, Valentyn Oksenych, Aleksandr Kamyshnyi
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes. Biomolecules 14 (4) (2024)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Aleksandr Kamyshnyi
Metformin Alters mRNA Expression of FOXP3 , RORC , and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses 16 (2) (2024)
Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Corticosteroid Treatment for Leptospirosis: A Systematic Review and Meta-Analysis. Journal of clinical medicine 13 (15) (2024)
Andrii Kamenshchyk, Belenichev Igor F, Valentyn Oksenych, Aleksandr Kamyshnyi
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes. Biomolecules 14 (4) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Aleksandr Kamyshnyi
Metformin Alters mRNA Expression of FOXP3 , RORC , and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes. Viruses 16 (2) (2024)
Iryna Halabitska, Liliia Babinets, Valentyn Oksenych, Aleksandr Kamyshnyi
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions. Biomedicines 12 (8) (2024)
Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Corticosteroid Treatment for Leptospirosis: A Systematic Review and Meta-Analysis. Journal of clinical medicine 13 (15) (2024)
Belenichev Igor F, Victor Ryzhenko, Olena Popazova, Nina Bukhtiyarova, Nadia Gorchakova, Valentyn Oksenych, Aleksandr Kamyshnyi
Optimization of the Search for Neuroprotectors among Bioflavonoids. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Pavlo Petakh, Mykhailo Poliak, Anton Kohutych, Valentyn Oksenych, Aleksandr Kamyshnyi
Impact of Antibiotic and Steroid Therapy on Leptospirosis Outcomes: A Retrospective Cohort Study in Transcarpathia, Ukraine. Biomedicines 12 (8) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense. Microorganisms 12 (3) (2024)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Aleksandr Kamyshnyi
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study. Viruses 16 (1) (2024)
Pavlo Petakh, Valentyn Oksenych, Yevheniya Khovpey, Aleksandr Kamyshnyi
Comprehensive Analysis of Antiphage Defense Mechanisms: Serovar-Specific Patterns. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Nikki Lyn Esnardo Upfold, Pavlo Petakh, Aleksandr Kamyshnyi, Valentyn Oksenych
Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 13 (3) (2023)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Denis E Kainov, Aleksandr Kamyshnyi
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Olena Popazova, Igor Belenichev, Nina Bukhtiyarova, Victor Ryzhenko, Valentyn Oksenych, Aleksandr Kamyshnyi
Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period after Intrauterine Hypoxia in Rats. Biomedicines 11 (10) (2023)
Andrii Kamenshchyk, Margaryta Gonchar, Valentyn Oksenych, Aleksandr Kamyshnyi
Association of Myocardial Changes and Gene Expression of the NFATC1 and NFATC4 -Calcineurin Signaling Pathway in Children with Bicuspid Aortic Valve. Children (Basel, Switzerland) 10 (9) (2023)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)
Kateryna Kozak, Halyna Pavlyshyn, Aleksandr Kamyshnyi, Oksana O Shevchuk, Mykhaylo M Korda, Sandor G Vari
The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism. Viruses 15 (10) (2023)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G Vari, Aleksandr Kamyshnyi
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. Viruses 15 (8) (2023)
Mykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, Nataliia Zavidniuk, Aleksandr Kamyshnyi
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence. Viruses 15 (5) (2023)
Pavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, Denis E Kainov, Aleksandr Kamyshnyi
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Aleksandr Kamyshnyi, Halyna Koval, Olha Kobevko, Mykhailo Buchynskyi, Valentyn Oksenych, Denis E Kainov, Katerina Lyubomirskaya, Iryna Kamyshna, Geert Potters, Olena V Moshynets
Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience. International journal of molecular sciences 24 (8) (2023)
Olena Popazova, Igor Belenichev, Oleh Yadlovskyi, Valentyn Oksenych, Aleksandr Kamyshnyi
Altered Blood Molecular Markers of Cardiovascular Function in Rats after Intrauterine Hypoxia and Drug Therapy. Current issues in molecular biology 45 (11) (2023)
Nikki Lyn Esnardo Upfold, Pavlo Petakh, Aleksandr Kamyshnyi, Valentyn Oksenych
Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 13 (3) (2023)
Nikki Lyn Esnardo Upfold, Pavlo Petakh, Aleksandr Kamyshnyi, Valentyn Oksenych
Tyrosine Kinase Inhibitors Target B Lymphocytes. Biomolecules 13 (3) (2023)
Pavlo Petakh, Vitaliia Isevych, Aleksandr Kamyshnyi, Valentyn Oksenych
Weil's Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules 12 (12) (2022)
Pavlo Petakh, Vitaliia Isevych, Aleksandr Kamyshnyi, Valentyn Oksenych
Weil's Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules 12 (12) (2022)
Pavlo Petakh, Vitaliia Isevych, Aleksandr Kamyshnyi, Valentyn Oksenych
Weil's Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules 12 (12) (2022)
Pavlo Petakh, Vitaliia Isevych, Aleksandr Kamyshnyi, Valentyn Oksenych
Weil's Disease-Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules 12 (12) (2022)
Dariush Haghmorad, Bahman Yousefi, Majid Eslami, Ali Rashidy-Pour, Mahdieh Tarahomi, Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, Aleksandr Kamyshnyi, Valentyn Oksenych
Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses. Current issues in molecular biology 44 (11) (2022)
Pavlo Petakh, Iryna Kamyshna, Andriy Nykyforuk, Rouan Yao, John F Imbery, Valentyn Oksenych, Mykhaylo Korda, Aleksandr Kamyshnyi
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword. Viruses 14 (3) (2022)